Maddrey's Discriminant Function for Alcoholic Hepatitis
ورودیهای بالینی بیمار
حداقل ۸ — حداکثر ۱۲۰ • واحد: seconds
حداقل ۸ — حداکثر ۲۰ • واحد: seconds
حداقل ۰.۱ — حداکثر ۵۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Mild to Moderate0–31
- Severe32–1000
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Hepatology, Alcoholic Hepatitis & GI Bleeding — بیماریهای کبدی، هپاتیت الکلی و خونریزی گوارشی
Clinical Rationale:
Assess chronic liver failure with Child-Pugh, MELD, and MELD-Na; evaluate alcoholic hepatitis severity with Maddrey and GAHS for steroid indication, and triage upper GI bleeding with Glasgow-Blatchford and AIMS65.
MELD Na (UNOS/OPTN)
امتیاز MELD-Na (UNOS/OPTN)
Recommended Clinical Next Steps:
Glasgow Alcoholic Hepatitis Score (GAHS)
امتیاز هپاتیت الکلی گلاسکو (GAHS)
Why next: Predict survival response to corticosteroid therapyGlasgow-Blatchford Bleeding Score (GBS)
امتیاز خونریزی گلاسکو-بلاچفورد (GBS)
Why next: Pre-endoscopy triage for outpatient safetyAIMS65 Score for Upper GI Bleeding Mortality
امتیاز AIMS65 (مرگومیر خونریزی گوارشی)
Why next: Rapid bedside mortality risk in acute upper GI bleeding
The Maddrey's Discriminant Function for Alcoholic Hepatitis calculates predicting prognosis and steroid benefit in alcoholic hepatitis. Key inputs include patient pt. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts prognosis and steroid benefit in alcoholic hepatitis
Clinical Indication
The Maddrey's Discriminant Function for Alcoholic Hepatitis is indicated for bedside clinical practice to support Predicts prognosis and steroid benefit in alcoholic hepatitis. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Should be used in conjunction with contraindications assessment for steroids.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Often combined with Lille score to assess treatment response.
Maddrey's DF = 4.6 × (Patient's PT - Control PT) + Total Bilirubin
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| patient_pt | float | Yes | Patient's prothrombin time (PT)(seconds) |
| control_pt | float | Yes | Control/reference prothrombin time (PT)(seconds) |
| total_bilirubin | float | Yes | Total bilirubin level(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–31 | Mild to Moderate | Good prognosis, steroid therapy not indicated |
| 32–1000 | Severe | Poor prognosis, consider steroid therapy |
Evidence-Based References (EBM)
- Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978 Aug;75(2):193-9. PMID: 352788.PMID: 352788
- Carithers RL Jr, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 1989 May 1;110(9):685-90. doi: 10.7326/0003-4819-110-9-685.DOI: 10.7326/0003-4819-110-9-685
- Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007 Jun;45(6):1348-54. doi: 10.1002/hep.21607.DOI: 10.1002/hep.21607